Kintara Therapeutics, Inc. (KTRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.02M |
| Enterprise Value | 193.9M |
| P/E Ratio | -4.42 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.01 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.52 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.04 |
| Return On Equity | -1.54 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -18.51B |
| Net Income | -22.65B |
| Diluted EPS | -1.21 |
| Total Cash | 6.3M |
| Total Cash/Share | 0.1 |
| Total Debt | 456,926 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.15 |
| Book Value Per Share | 0.39 |
| 52-Week Change | -98.15 |
| 52-Week High | 26.21 |
| 52-Week Low | 0.2 |
| Moving Average 50 Days | 6.67 |
| Moving Average 200 Days | 6.02 |
| Average Volume | 83,392 |
| Shares Outstanding | 55.66M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | 1:50 |
| Last Split Date | November 14, 2022 |